From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer
Cancers · 20.01.2025 · 17 (2) · 320
DOI: 10.3390/cancers17020320 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.01.2025. Verfasst von Thulo Molefi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Obstetrics and Gynaecology, School of Clinical Medicine, University of KwaZulu-Natal, Durban 4002, South Africa. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council (SAMRC), National Research Foundation (NRF).
Abstract (Originalsprache)
Endometrial cancer (EC), a prevalent gynecological malignancy, presents significant challenges due to its genetic complexity and heterogeneity. The genomic landscape of EC is underpinned by genetic alterations, such as mutations in PTEN, PIK3CA, and ARID1A, and chromosomal abnormalities. The identification of molecular subtypes—POLE ultramutated, microsatellite instability (MSI), copy number low, and copy number high—illustrates the diverse genetic profiles within EC and underscores the need for subtype-specific therapeutic strategies. The integration of multi-omics technologies such as single-cell genomics and spatial transcriptomics has revolutionized our understanding and approach to studying EC and offers a holistic perspective that enhances the ability to identify novel biomarkers and therapeutic targets. The translation of these multi-omics findings into personalized medicine and precision oncology is increasingly feasible in clinical practice. Targeted therapies such as PI3K/AKT/mTOR inhibitors have demonstrated the potential for improved treatment efficacy tailored to specific genetic alterations. Despite these advancements, challenges persist in terms of variability in patient responses, the integration of genomic data into clinical workflows, and ethical considerations. This review explores the genomic underpinnings of EC, from genes to clinical practice. It highlights the ongoing need for multidisciplinary research and collaboration to address the complexities of EC and improve diagnosis, treatment, and patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Discipline of Obstetrics and Gynaecology, School of Clinical Medicine, University of KwaZulu-Natal, Durban 4002, South Africa.
- SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), Pan African Research Institute (PACRI), University of Pretoria, Hartfield, Pretoria 0028, South Afr…
- Department of Medical Oncology, University of Pretoria, Hatfield, Pretoria 0028, South Africa.
ORCID-Profile: Thulo Molefi, Lloyd Mabonga, Rodney Hull, Zodwa Dlamini
Förderung
- South African Medical Research Council (SAMRC)
- National Research Foundation (NRF)
Zitieren
APA
Molefi, T., Mabonga, L., Hull, R., Sebitloane, M., & Dlamini, Z. (2025). From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer. Cancers, 17(2), 320. https://doi.org/10.3390/cancers17020320
Vancouver
Molefi T, Mabonga L, Hull R, Sebitloane M, Dlamini Z. From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer. Cancers. 2025;17(2):320. doi:10.3390/cancers17020320
BibTeX
@article{Molefi2025,
author = {Molefi, Thulo and Mabonga, Lloyd and Hull, Rodney and Sebitloane, Motshedisi and Dlamini, Zodwa},
title = {From Genes to Clinical Practice: Exploring the Genomic Underpinnings of Endometrial Cancer},
journal = {Cancers},
year = {2025},
volume = {17},
number = {2},
pages = {320},
doi = {10.3390/cancers17020320}
}
EUVIMED